New drug milsaperidone aims to boost depression treatment
NCT ID NCT06830044
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 3 study tests whether adding milsaperidone to standard antidepressant therapy helps adults with major depressive disorder who still have symptoms. About 500 participants will receive either milsaperidone or a placebo, and researchers will measure changes in depression severity using a standard rating scale.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- milsaperidone (also called VHX-896)
- What this could lead to
- If it works, this could provide a new add-on treatment option for people with major depressive disorder who haven't gotten enough relief from standard antidepressants.
- What could go wrong
- This is a Phase 3 trial, but it's still experimental. The drug may not prove more effective than placebo, and side effects are possible. Results may not apply to all patients with depression.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Vanda Investigational Site
RECRUITINGPhoenix, Arizona, 85012, United States
-
Vanda Investigational Site
RECRUITINGLittle Rock, Arkansas, 72211, United States
-
Vanda Investigational Site
RECRUITINGGarden Grove, California, 92845, United States
-
Vanda Investigational Site
RECRUITINGLemon Grove, California, 91945, United States
-
Vanda Investigational Site
RECRUITINGOrange, California, 92868, United States
-
Vanda Investigational Site
RECRUITINGSan Jose, California, 95124, United States
-
Vanda Investigational Site
RECRUITINGWalnut Creek, California, 94596, United States
-
Vanda Investigational Site
RECRUITINGColorado Springs, Colorado, 80910, United States
-
Vanda Investigational Site
RECRUITINGFort Myers, Florida, 33912, United States
-
Vanda Investigational Site
ACTIVE_NOT_RECRUITINGMiami, Florida, 33135, United States
-
Vanda Investigational Site
RECRUITINGMiami, Florida, 33173, United States
-
Vanda Investigational Site
ACTIVE_NOT_RECRUITINGTampa, Florida, 33614, United States
-
Vanda Investigational Site
RECRUITINGChicago, Illinois, 60634, United States
-
Vanda Investigational Site
RECRUITINGSaint Charles, Missouri, 63304, United States
-
Vanda Investigational Site
RECRUITINGLas Vegas, Nevada, 89119, United States
-
Vanda Investigational Site
RECRUITINGNew York, New York, 10035, United States
-
Vanda Investigational Site
RECRUITINGStaten Island, New York, 10314, United States
-
Vanda Investigational Site
RECRUITINGMedia, Pennsylvania, 19063, United States
-
Vanda Investigational Site
RECRUITINGRichardson, Texas, 75080, United States
-
Vanda Investigational Site
RECRUITINGWitchita Falls, Texas, 76309, United States
-
Vanda Investigational Site
RECRUITINGBellevue, Washington, 98007, United States
-
Vanda Investigational Site
RECRUITINGSofia, 1202, Bulgaria
-
Vanda Investigational Site
RECRUITINGSofia, 1618, Bulgaria
-
Vanda Investigational Site
RECRUITINGSofia, 1680, Bulgaria
-
Vanda Investigational Site
RECRUITINGTargovishte, 7700, Bulgaria
-
Vanda Investigational Site
RECRUITINGVarna, 9020, Bulgaria
-
Vanda Investigational Site
RECRUITINGBrno, 60200, Czechia
-
Vanda Investigational Site
RECRUITINGPilsen, 30100, Czechia
-
Vanda Investigational Site
RECRUITINGPoruba, 70800, Czechia
-
Vanda Investigational Site
RECRUITINGPrague, 100 00, Czechia
-
Vanda Investigational Site
RECRUITINGPrague, 15000, Czechia
-
Vanda Investigational Site
RECRUITINGPrague, 16000, Czechia
-
Vanda Investigational Site
RECRUITINGBialystok, 15-756, Poland
-
Vanda Investigational Site
RECRUITINGBydgoszcz, 85-794, Poland
-
Vanda Investigational Site
RECRUITINGGdansk, 80-952, Poland
-
Vanda Investigational Site
RECRUITINGKatowice, 40-514, Poland
-
Vanda Investigational Site
RECRUITINGKatowice, 40-600, Poland
-
Vanda Investigational Site
RECRUITINGSuchy Las, 62-002, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can couples counseling lift depression in women?
- Brain wave clues: could inflammation markers forecast ECT outcomes?
- Can tailored brain zaps beat standard therapy for depression?
- Can a new daily pill lift the fog of depression?
- Can a new pill outsmart depression? a trial puts KH607 to the test
- Depression's biological fingerprint: a quest for objective diagnosis and personalized treatment